Stryker C2 NerveMonitor's design and instructions may not optimally address usability issues related to
the functionality of the device, which may result in use errors potentially causing or contributing to nerve
injury.
Source facts
Action
On July 31, 2019, the firm distributed an Urgent Medical Device Recall Notification to its consignees to inform them of the recall.
Customers were asked to do the following:
1. Immediately review the Recall Notification and this Business Reply Form (BRF).
2. Inform all users of the Stryker C2 NerveMonitor of the information contained in this recall notification.
3. Check all treatment areas, operating rooms and/or storage areas for affected products.
4. Determine a plan to transition to an alternative commercially available product. Document your
transition date on the BRF. This transition date must be no later than January 31, 2020.
5. Complete page 2 of BRF to confirm receipt of this Notification, identify how many affected items are
currently in your inventory, and provide the date you will transition to alternative product and return your
Stryker C2 NerveMonitor. Upon receipt of your returned device(s), Stryker will work with your facility to
issue a refund or credit.
Please complete and return the BRF even if you dont have any affected product on hand.
6. Fax the completed BRF to Stryker Instruments at 8665212762, or email to kara.spath@stryker.com.
7. If you have further distributed this product, please forward copies of the Notification and this BRF to all
affected locations, for each location to complete and return. Even if you have distributed all product to
another location, please complete a BRF and indicate each location that received product.
Initiated
2019-07-31
Root cause
Device Design
Terminated
2021-03-24
Distribution
US Nationwide distribution.
Recall number
Z-0023-2020
Recall status
Terminated
CDRH record ID
175420
FDA record created
2019-10-01
Recall event number
83490
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.